Safety of Intravenous Thrombolytics in Stroke on Awakening "SAIL-ON"


Phase 2 Results N/A

Summary of Purpose

The primary objective of this study is to evaluate the safety of intravenous tPA in patients waking up with symptoms of acute stroke and presenting to the ED within 4.5 hours from awakening, and meeting standard criteria for treatment with IV tPA for acute stroke. The hypothesis is that patients that wake up with stroke symptoms may have developed the stroke at the time of awakening, and may be within the 4.5...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 January 2014.

1 Jan 2013 16 Jul 2012 1 Jul 2014 1 Dec 2014 1 Jan 2014 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Non-Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment